Many bioactive compounds derived from natural plants have been shown to have the ability to regulate lncRNA expression via molecular mechanisms, and MEG3 research may offer new strategies for finding pharmacotherapy in the treatment of cardio-cerebrovascular diseases. This evidence concerns the gene MEG3 and cerebrovascular disorder.